Business Context and Reporting Period
This Form 8-K is a current report filed by Healthcare Triangle, Inc. (HCTI) on February 26, 2025. The filing addresses multiple compliance issues with The Nasdaq Stock Market LLC, including a new notice regarding minimum bid price requirements and ongoing matters related to stockholders' equity and corporate governance.
Key Financial Metrics
This filing is a current report regarding listing compliance and does not contain financial statements. Consequently, specific values for revenue, profit, cash flow, margins, debt, and liquidity are not provided in this document.
Material Changes and Listing Status
- Minimum Bid Price Deficiency: The Company received a "Bid Price Notice" from Nasdaq stating that for the last 30 consecutive business days prior to February 26, 2025, the closing bid price of its common stock was below the $1.00 per share minimum required by Nasdaq Listing Rule 5550(a)(2).
- Compliance Timeline: Nasdaq has granted the Company 180 calendar days (until August 25, 2025) to regain compliance. Compliance requires the closing bid price to be at least $1.00 per share for a minimum of 10 consecutive business days during this period.
- Stockholders' Equity History: The Company previously failed to meet the $2,500,000 stockholders' equity requirement (notified March 20, 2024). After a delisting determination in September 2024, the Nasdaq Hearings Panel granted continued listing subject to conditions in late 2024.
- Corporate Governance Deficiency: On January 14, 2025, Nasdaq noted non-compliance regarding the failure to hold an annual meeting of shareholders within 12 months of the fiscal year end. This is now an additional basis for potential delisting.
Guidance, Outlook, and Management Commentary
- Remediation Plan: Management intends to monitor the stock price and, if necessary, implement a reverse stock split to regain compliance with the minimum bid price requirement.
- Second Compliance Period: If the Company fails to regain compliance by August 25, 2025, it may be granted an additional 180 days, provided it meets other listing standards and notifies Nasdaq of its intention to cure the deficiency (potentially via a reverse stock split).
- Annual Meeting: The Board has scheduled the 2024 Annual Meeting of Stockholders for March 28, 2025, to address the governance non-compliance. Stockholder proposals and director nominations must be received by March 5, 2025.
- Forward-Looking Statements: The Company cautions that actual results may differ materially from expectations regarding compliance timelines and stock price performance.
Investor Verification Checklist
- Verify the current trading price of HCTI to assess the likelihood of meeting the $1.00 bid price requirement within the 180-day window.
- Monitor for a definitive proxy statement regarding the March 28, 2025 Annual Meeting to confirm the resolution of the governance deficiency.
- Watch for announcements regarding a potential reverse stock split if the stock price does not recover organically.
- Review the Company's most recent 10-K or 10-Q filings to assess the status of the stockholders' equity requirement, as this filing does not provide updated financial figures.